PLURISTEM THERAPEUTICS INC - COM (PSTI)

CUSIP: 72940R102

Q3 2018 13F Holders as of 30 Sep 2018

Type / Class
Equity / COM
Total 13F shares
5,884,334
Share change
+1,881,438
Total reported value
$7,646,520
Put/Call ratio
56%
Price per share
$1.30
Number of holders
33
Value change
+$2,456,356
Number of buys
14
Number of sells
14

Quarterly Holders Quick Answers

What is CUSIP 72940R102?
CUSIP 72940R102 identifies PSTI - PLURISTEM THERAPEUTICS INC - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of PLURISTEM THERAPEUTICS INC - COM (PSTI) as of Q3 2018

As of 30 Sep 2018, PLURISTEM THERAPEUTICS INC - COM (PSTI) was held by 33 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 5,884,334 shares. The largest 10 holders included ARK Investment Management LLC, RENAISSANCE TECHNOLOGIES LLC, B. Riley Financial, Inc., CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM, ETF MANAGERS GROUP, LLC, Psagot Investment House Ltd., GEODE CAPITAL MANAGEMENT, LLC, RAYMOND JAMES & ASSOCIATES, JANE STREET GROUP, LLC, and Virtu Financial LLC. This page lists 33 institutional shareholders reporting positions in this security for the Q3 2018 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.